R9N-14469-19512
3 vaccinations
2 coded responses
7 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 274 / NC
- Registered
- 2021-02-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Dose 1 — Pfizer-BioNTech
-
2021-01-21
Dose 2 — Pfizer-BioNTech
-
2021-02-25
Registered in v-safe
- 2021-02-26
- 2021-03-04
-
2021-04-22
Survey response — 3 months, dose 2MedDRA: Nasal congestion, Rhinorrhoea — Feeling: GoodFree text: I had 4 days of nasal congestion and runny nose that resolvedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-22
-
2021-11-22
Dose 3 — Pfizer-BioNTech
-
2022-01-21
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
- 2022-05-23
- 2022-11-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Pfizer-BioNTech | |
| 2 | 2021-01-21 | Pfizer-BioNTech | |
| 3 | 2021-11-22 | Pfizer-BioNTech | No |
Free text
Release 7 — 3 months, dose 2
Symptoms: I had 4 days of nasal congestion and runny nose that resolved
Release 11 — 12 months, dose 2
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release